Citius Pharmaceuticals to Present at Biotech Showcase Investor Conference
Updated: Jan 28, 2019
CRANFORD, N.J., Jan. 4, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") ( CTXR ), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that its Chief Executive Officer, Mr. Myron Holubiak, will present at the Biotech Showcase Investor Conference. The conference will be held on January 7-9, 2019 at the Hilton San Francisco Union Square.
During the conference, Mr. Holubiak will deliver the Company's corporate presentation and discuss recent business highlights and updates on Mino-Lok® and CITI-002. Management will also be available for one-on-one meetings.
To arrange a meeting with management, please contact Mr. Andrew Scott: ascott(at)citiuspharma(dot)com.
About Biotech Showcase Investor Conference
iotech Showcase™ is an investor conference, during JPM 2019, devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco during this bellwether week which sets the tone for the coming year.
Now in its eleventh year, this rapidly growing conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings.
In addition to biopharmaceutical and life science company executives, Biotech Showcase delegates include investors in private and public companies, sector analysts, bankers and industry professionals.
Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high quality programs that support the biotechnology and broader life sciences industry.